Bristol-Myers Squibb Co (BMY)

Bristol-Myers Squibb Co (BMY)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Bristol-Myers Squibb Co (BMY) Profile

Biopharmaceutical products are developed, manufactured and marketed by Bristol-Myers Squibb. The company sells products in hematology, oncology, cardiology, and immunology. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma, Opdivo, an anti-cancer drug, Eliquis, an oral inhibitor for the prevention of stroke/systemic embolism in patients with NVAF, and Orencia, for the management of DVT/PE in adults. It also offers Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia, Yervoy for unresectable or metastatic melanoma, Abraxane, a protein-bound chemotherapeutic product, mpliciti for multiple myeloma, and Reblozyl for anemia in adult beta thalassemia sufferers. It also offers Onureg for AML, Zeposia for relapsing MS, Vidaza for MDS subtypes, Baraclude, an oral antiviral for chronic hepatitis B, and Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for relapsed or refractory large B-cell lymphoma. Companies such as this one sell to hospitals and government agencies as well as wholesalers. • Pfizer; Otsuka; Ono; Nektar; AVEO; Huyabio; Darwin Health; Inspirna; and Bolt Biotherapeutics; Originally known as Bristol-Myers Squibb. Bristol-Myers Squibb is headquartered in New York, New York.

Full Time Employees: 30,250. Latest stock price 64.72-0.17 (-0.26%) At close: 04:00PM EST.19th January 2022, Total assets for the quarter ending September 30, 2021 were $110.893B, Subsidiaries: Celgene, MyoKardia, Inc., Juno Therapeutics, Union de Pharmacologie Scientifique Appliquée, Bristol Myers Squibb Pharmaceuticals and more.

Bristol-Myers Squibb Co (BMY.xnys) Analysis
Thu, January 20, 2022, 5:50 AM Bristol Myers Squibb (BMY) closed the most recent trading day at $64.72, moving -0.26% from the previous trading session. This change was narrower than the S&P 500's daily loss of 0.97%. Meanwhile, the Dow lost 0.96%, and the Nasdaq, a tech-heavy index, added 0.23%.

Holding cost
Long
-5%
Short
-2.5%
Trading hours in US Eastern Time
Fri
10:00 - 18:30
Mon
10:00 - 18:30
Tue
10:00 - 18:30
Wed
10:00 - 18:30
Thu
10:00 - 18:30
Sun
Closed
Sat
Closed

Start Trading Bristol-Myers Squibb Co (BMY)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.





Get instant Updates in Telegram
Sitemap | © FP Markets 2022